Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyFibroTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyFibroTeam Member asked a question 💭

“Amatica exists for one reason: to move ME/CFS, Long COVID and chronic disease care away from guesswork by learning from large-scale, real-world patient data, and ultimately to match patients to effective treatments and improve care for the entire patient population.

2025 at a glance
In 2025, Amatica Health:

Launched publicly in January 2025

Grew to nearly 300 unique patients contributing health history, questionnaires, and blood samples

Rolled out two core testing modalities:

A 31-marker… read more

May 10
 · 
Reactions
A MyFibroTeam Member

Great question!
My own limited experience and understanding is: there are specialty clinics such as the one in Florida, US, where a doctor who focuses on ME/CFS (Dr. Nancy Klimas) can test for highly specific things.

However, I think most long covid clinics and in general, doctors helping patients with LC or ME/CFS will routinely order labs to rule out anything else that might be going on and focus on what's considered best practices in terms of what's prescribed (as in Stanford).

Unfortunately I've heard of some well known clinics still pushing G.E.T. and CBT for people who literally are diagnosed with ME/CFS, i.e. they experience PEM. 💔

The 2026 International ME/CFS Conference took place on May 7–8, 2026, in Berlin:
https://events.mecfs-research.org/en/events/con...

The history of diagnosing and treating ME/CFS is like a combination mystery novel and horror movie. It's amazingly detailed in a book I want to recommend highly:
Through the Shadowlands: A Science Writer's Odyssey into an Illness Science Doesn't... by Julie Rehmeyer

ME/CFS Research Foundation
ME/CFS Research Foundation
May 10 (edited)
A MyFibroTeam Member

https://pbs.twimg.com/media/HHt62ksW0Acy1By?for...
2026 ME/CFSConference

2026 ME/CFS 2026 Conference
May 7-8 2026

May 10 (edited)
A MyFibroTeam Member

amaticahealth.com also discusses 3 topics on their site.

1) Reduced BH1/BH2 ratio in LC and ME/CFS.
A metabolic window in vascular and neurological disfunction.

2)HIF1a elevation correlated with mitochondrial, fibrotic, and immunosuppressive protein in a subset of ME/CFS and LC patients.

3) TGFB2 elevated in subgroup of ME/CFS andLC patients. Correlation with hypoxia and mitochondrial recycling related protein.

( I posted this Q and A because so many with fibromyalgia have ME/CFS.)

* Site mentioned that if one was in a POTS flare, that could be noticed in the blood draw…..

May 10 (edited)
A MyFibroTeam Member

Pop on Google. All the information you need is there about all the questions you asked 🌻✨️🌼

May 10
MyFibroTeam

That's a really interesting question! While Amatica Health's research is focused on conditions that aren't fibromyalgia, there's a reason this might still feel relevant to you.

Fibromyalgia is notoriously difficult to diagnose because there's no single definitive test for it. Doctors currently diagnose it by:

- Ruling out Show Full Answer

That's a really interesting question! While Amatica Health's research is focused on conditions that aren't fibromyalgia, there's a reason this might still feel relevant to you.

Fibromyalgia is notoriously difficult to diagnose because there's no single definitive test for it. Doctors currently diagnose it by:

- Ruling out other conditions through blood tests and imaging
- Confirming widespread pain lasting at least 3 months
- Assessing fatigue and cognitive symptoms

The exciting part of research like Amatica's is that it points toward a future where blood-based biological markers could help identify and differentiate complex chronic conditions more objectively. That kind of progress could eventually benefit fibromyalgia diagnosis and treatment matching too.

Low-dose naltrexone (LDN), mentioned in the Amatica data, is actually already being explored as a treatment option for fibromyalgia, which shows some overlap in research directions.

It's always worth discussing emerging research with your doctor, especially if you're curious whether any current testing or treatments being studied might apply to your specific situation.

May 10

Related Questions

View All
A MyFibroTeam Member asked a question 💭

A MyFibroTeam Member asked a question 💭
Batavia, IL

A MyFibroTeam Member asked a question 💭